COX-2 and PPARγ expression are potential markers of recurrence risk in mammary duct carcinoma in-situ

BACKGROUND: In women with duct carcinoma in-situ (DCIS) receiving breast conservation therapy (BCT), in-breast recurrences are seen in approximately 10%, but cannot be accurately predicted using clinical and histological criteria. We performed a case-control study to identify protein markers of loca...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, Swati, Patil, Deepa B, Diaz, Leslie K, Wiley, Elizabeth L, Morrow, Monica, Khan, Seema A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2254431/
https://www.ncbi.nlm.nih.gov/pubmed/18237383
http://dx.doi.org/10.1186/1471-2407-8-36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2254431/
https://www.ncbi.nlm.nih.gov/pubmed/18237383
http://dx.doi.org/10.1186/1471-2407-8-36

Ejemplares similares